Issue 6, 2010

Dynamics of bionanoparticle targeting in mixtures of human tumour cells by validated population balance modelling

Abstract

Preferential aggregation of bionanoparticles to different human suspension cell lines preceding cellular uptake by endocytosis was investigated by a 3-dimensional discrete population balance model. Property space was reduced by excluding intercellular aggregation in accordance with experimental evidence and by establishing an adaptive grid with full property resolution in areas of high particle or cell densities. The aggregation rates are based on deterministic models from colloidal sciences, adapted to include biologically specific aggregation in addition to unspecific aggregation. While the collision frequency is described by the Smoluchowski kernel for Brownian motion, the collision efficiency is modelled by a kernel considering inhomogeneous surface patches. The patch encounter probability and the interaction potential energies embedded in the stability ratio gain dominant influence on the aggregation kinetics.

Given a cell specific receptor density as input parameter, the preferential aggregation of bionanoparticles to U-937 cells in mixture with KARPAS-299 cells was successfully simulated. Fast specific biological aggregation is superimposed on slow unspecific aggregation. The distribution of adsorbed bionanoparticles per cell initially broadens considerably until all receptors are saturated, then narrows down to a quasi-equilibrium state where only unspecific aggregation persists. A low probability of bionanoparticle-receptor encounters, based on considerations concerning cell and receptor geometries, causes a rate limitation of biologically specific aggregation despite the high bionanoparticle to cell concentration ratio and purely attractive interaction potentials.

Validation experiments with IgG1, CD13 and CD33 antibodies were performed by flow cytometry. By appropriate gating separate aggregation dynamics could be gained for each cell type. Since the expression levels of antigens on the cell surfaces vary between the experiments and because the quantification of adsorbed antibody numbers remains difficult, dimensionless experimental data is compared to the simulations with very good agreement. Selective and specific drug delivery to target cells might represent a future application of this principle.

Graphical abstract: Dynamics of bionanoparticle targeting in mixtures of human tumour cells by validated population balance modelling

Article information

Article type
Paper
Submitted
14 Sep 2009
Accepted
30 Nov 2009
First published
18 Jan 2010

Soft Matter, 2010,6, 1203-1216

Dynamics of bionanoparticle targeting in mixtures of human tumour cells by validated population balance modelling

S. Rollié, U. Lendeckel, M. Naumann, U. Reichl and K. Sundmacher, Soft Matter, 2010, 6, 1203 DOI: 10.1039/B919122D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements